CLINICAL TRIALS PROFILE FOR MYDAYIS
✉ Email this page to a colleague
All Clinical Trials for MYDAYIS
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT03945175 ↗ | Study of the Duration and Efficacy of MYDAYIS on Adult ADHD Symptoms and Executive Function Throughout the Day Into the Early Evening | Recruiting | New York University School of Medicine | Phase 3 | 2020-07-15 | Attention-deficit/hyperactivity disorder (ADHD) is a neuropsychiatric disorder characterized by problems with sustaining attention, organization, planning, procrastination, daydreaming, restlessness, impulsivity and hyperactivity.This is an outpatient study for subjects between the ages of 18-60, who have an Attention deficit hyperactivity disorder (ADHD) diagnosis meeting all inclusion criteria and not meeting any of the exclusion criteria. |
NCT03945175 ↗ | Study of the Duration and Efficacy of MYDAYIS on Adult ADHD Symptoms and Executive Function Throughout the Day Into the Early Evening | Recruiting | NYU Langone Health | Phase 3 | 2020-07-15 | Attention-deficit/hyperactivity disorder (ADHD) is a neuropsychiatric disorder characterized by problems with sustaining attention, organization, planning, procrastination, daydreaming, restlessness, impulsivity and hyperactivity.This is an outpatient study for subjects between the ages of 18-60, who have an Attention deficit hyperactivity disorder (ADHD) diagnosis meeting all inclusion criteria and not meeting any of the exclusion criteria. |
NCT04235686 ↗ | 8 Week Multi-site Study of MYDAYIS® for Bipolar Depression | Recruiting | Lindner Center of HOPE | Phase 2 | 2020-07-17 | This protocol is a Phase 2 multi-site study which aims to evaluate the safety and effectiveness of MYDAYIS® as adjunctive therapy for adults with bipolar depression. Results from this study WILL NOT be used to contribute to an approval of MYDAYIS ® for this indication. |
NCT04235686 ↗ | 8 Week Multi-site Study of MYDAYIS® for Bipolar Depression | Recruiting | Mayo Clinic | Phase 2 | 2020-07-17 | This protocol is a Phase 2 multi-site study which aims to evaluate the safety and effectiveness of MYDAYIS® as adjunctive therapy for adults with bipolar depression. Results from this study WILL NOT be used to contribute to an approval of MYDAYIS ® for this indication. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for MYDAYIS
Condition Name
Clinical Trial Locations for MYDAYIS
Trials by Country
Clinical Trial Progress for MYDAYIS
Clinical Trial Phase
Clinical Trial Sponsors for MYDAYIS
Sponsor Name